Cambridge spinout Paragraf has been backed by the university's commercialisation arm Cambridge Enterprise in its bid to deliver a commercial graphene production process.
Paragraf, a UK-based graphene technology spinout from University of Cambridge, closed a £2.9m ($4m) seed round yesterday led by the university’s commercialisation arm, Cambridge Enterprise.
Parkwalk Advisors, the spinout-focused fund manager owned by commercialisation firm IP Group, also provided funding, as did Amadeus Capital Partners, IQ Capital Partners and unspecified angel investors.
The spinout previously raised an initial $3.6m tranche from Cambridge Enterprise and Parkwalk Advisors in October 2017.
Paragraf has designed a manufacturing process to produce commercial quantities…
